HCPs see biosimilars as solution to tackle rising costs: GlobalData
Express Pharma
JUNE 22, 2023
Healthcare professionals (HCPs) believe that biosimilars could provide costs savings for the patients and healthcare systems and their use should be encouraged, according to a survey by GlobalData. The only exception was Japan were physicians seemed to be more reluctant about biosimilar use.
82 
Let's personalize your content